Vitamin A supplementation in neonates
Vitamin A deficiency is a public health problem in many countries. In infants, vitamin A is essential to support rapid growth and to help combat infections. Babies are born with low vitamin A stores and are dependent on external sources – most importantly breast milk – to receive this vitamin, but in areas where the availability of foods rich in vitamin A is low, breast milk does not have adequate concentrations of vitamin A.
Vitamin A supplementation during the neonatal period was initially proposed as a means to increase baby’s vitamin A stores, and more recently as a strategy to improve infant survival. However, the clinical trials investigating the impact of this intervention on infant morbidity and mortality have so far provided inconsistent findings.
At this time, the WHO does not recommended neonatal vitamin A supplementation as a public health intervention. As there are four ongoing trials that are expected will help clarify the efficacy and safety of this intervention, the current recommendations will be reviewed in 2013.
WHO documents
-
Neonatal vitamin A supplementation [pdf 657kb]
Status: published
Publication year: 2011
Approved by the WHO Guidelines Review Committee
Evidence
Cochrane review
Other systematic reviews
-
Neonatal vitamin A supplementation and infant survival
Kirkwood et al.
The Lancet, 2010, 376(9753):1643–1644
doi:10.1016/S0140-6736(10)61895-8 -
Vitamin A supplementation and neonatal mortality in the developing world: a meta-regression of cluster-randomized trials
Rotondi MA, Khobzi N.
Bulletin of the World Health Organization, 2010, 88(9):697–702
doi:10.2471/BLT.09.068080 -
Neonatal vitamin A supplementation for prevention of mortality and morbidity in infancy: systematic review of randomised controlled trials
Gogia S, Singh Sachdev H.
British Medical Journal, 2009, 338:b919
doi:10.1136/bmj.b919